Novel Influenza A (H1N1) infection vs. common Influenza-Like Illness: A prospective study

Medical Science Monitor

Volumn 17, Issue 4, 2011, Pages 185-188

  Voudoukis, Evangelos ^a   Pappas, Apostolos ^a   Panoutsopoulos, Athanasios ^a   Xynos, Konstantinos ^a   Rozi, Fotini ^a   Giannakopoulou, Konstantina ^a   Paulaki, Maria ^a   Stofa, Euthimia ^a   Seretis, Charalampos ^b   Lagoudianakis, Emmanouil ^b   Andrianopoulos, George ^a  

^a Department of Internal Medicine of General Hospital of Argos ^*  (Greece)

^b 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

Author keywords

H1NI; Infections; Influenza virus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; HOSPITAL ADMISSION; HUMAN; INFLUENZA; INFLUENZA A (H1N1); LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; REAL TIME POLYMERASE CHAIN REACTION; THROAT CULTURE;

EID: 79953717730     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881713     Document Type: Article

References (20)

1. Zimmer SM, Burke DS: Historical perspective-emergence of influenza A (H1N1) viruses. N Engl J Med, 2009; 361(3): 279-85
2. Garten RJ, Davis CT, Russell CA et al: Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 2009; 325: 197-201
3. WHO: Pandemic (H1N1) 2009 briefi{dotless}ng note 3. Changes in reporting requirements for pandemic(H1N1)2009virusinfection. www. who.int/ csr/disease/swineflu/notes/h1n1_surveillance_20090710/en/index.html
4. WHO: Pandemic (H1N1) 2009-update 91. www. who.int/csr/don/ 2010_03_12/en/index.html
5. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ et al: Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet, 2009; 374(9707): 2072-79
6. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al, INER Working Group on Influenza: Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med, 2009; 361(7): 680-89
7. Archer B, Cohen C, Naidoo D et al: Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. Euro Surveill, 2009; 14(42): pii: 19369
8. Centers for Disease Control and Prevention (CDC): 2009 pandemic influenza A (H1N1) virus infections-Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep, 2009; 58(33): 913-18
9. Louie JK, Acosta M, Winter K et al, California Pandemic (H1N1) Working Group: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA, 2009; 302(17): 1896-902
10. Hancock K, Veguilla V, Lu X et al: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med, 2009; 361(20): 1945-52
11. Plennevaux E, Sheldon E, Blatter M et al: Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet, 2010; 375(9708): 41-48
12. Deans GD, Stiver HG, McElhaney JE: Influenza vaccines provide diminished protection but are cost-saving in older adults. J Intern Med, 2010; 267(2): 220-27
13. Fraser C, Donnelly CA, Cauchemez S et al: Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009; 324(5934): 1557-61
14. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T et al: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care, 2009; 13(6): R201
15. Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A et al: Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One, 2009; 4(12): e8393
16. National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC): Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep, 2009; 58(RR-10): 1-8
17. Centers for Disease Control and Prevention (CDC): Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage-United States, October-December 2009. MMWR Morb Mortal Wkly Rep, 2010; 59(2): 44-48
18. Liang XF, Wang HQ, Wang JZ et al: Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, doubleblind, randomised, placebo-controlled trial. Lancet, 2010; 375(9708): 56-66
19. Vajo Z, Tamas F, Sinka L, Jankovics I: Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet, 2010; 375(9708): 49-55
20. Pfeifer D, Alfonso C, Wood D: Defining the safety profile of pandemic influenza vaccines. Lancet, 2010; 375(9708): 9-11